Nascent Biotech

Nascent Biotech, Inc. is a California-based company focused on developing and delivering human antibody and cytokine responses for cancer treatment. Nascent Biotech, Inc. is utilizing and developing human antibody and cytokine responses derived from the body's inherent natural immune response as a drug discovery platform to identify new antibodies and antigens for commercialization. Our insights into the body’s natural immune response define critical targets for therapeutic intervention, enabling the rapid advancement of safe, non-toxic, and specific novel biologics in clinical applications. The company’s technology portfolio is based on the natural human immune system, uniquely leveraging the immune system's innate capabilities and selectivity to generate potent immune-enhancing and modulating biomolecules.